Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Part 1 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data from the ACTT-1 trial comparing remdesivir vs placebo for severe COVID-19 treatment. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, diagnosis, and management.
Content based on an online CME program supported by an independent educational grant from Gilead Sciences.
Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources
Download free slides from CCO reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis and transmission
Download free slides from CCO reviewing the latest data and guidance on COVID-19 treatments, including authorized and investigational agents
Download free slides from CCO reviewing the latest data and guidance on COVID-19 symptoms and the prevalence and duration of natural immunity
Download free slides from CCO reviewing the latest data and guidance on COVID-19 risk and management in special populations and persons with comorbidities